The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail

Nobilis ND C2 lyophilisate for oculonasal suspension for chickens

Intervet Ireland LimitedVPA10996/187/001

Main Information

Trade NameNobilis ND C2 lyophilisate for oculonasal suspension for chickens
Active SubstancesLive attenuated newcastle disease virus (ndv) strain c2
Dosage FormLyophilisate for oculonasal suspension
Licence HolderIntervet Ireland Limited
Licence NumberVPA10996/187/001

Group Information

ATC CodeQI01AD06 newcastle disease virus / paramyxovirus
Therapeutic ClassImmunological - Live Vaccine


Licence Issued03/06/2005
Legal StatusPOM: Prescription Only Medicine as defined in relevant national legislation


Summary of Product CharacteristicsPDF Version
Package LeafletNo document available
Public Assessment ReportNo document available
« Back